Socio-demographic determinants of Monkeypox virus preventive behavior: A cross-sectional study in Pakistan
PLOS ONE
RESEARCH ARTICLE
Socio-demographic determinants of
Monkeypox virus preventive behavior: A
cross-sectional study in Pakistan
Hashaam Jamil ID1, Muhammad Idrees ID2, Kashmala Idrees1, Waleed Tariq ID1,
Qudsia Sayyeda3, Muhammad Sohaib Asghar ID4, Muhammad Junaid Tahir5,
Samra Akram1, Kaleem Ullah ID6, Ali Ahmed ID7, Aroop Mohanty8, Bijaya Kumar Padhi9,
Ranjit Sah ID10,11,12*
a1111111111
a1111111111
a1111111111
a1111111111
a1111111111
1 Lahore General Hospital, Lahore, Pakistan, 2 Multan Institute of Kidney Diseases, Multan, Pakistan, 3 Red
Crescent of Tampa Bay, Tampa, FL, United States of America, 4 Mayo Clinic, Rochester, MN, United States
of America, 5 Pakistan Kidney and Liver Institute and Research Center, Lahore, Pakistan, 6 Pir Abdul Qadir
Shah Jeelani Institute of Medical Sciences, Gambat, Pakistan, 7 School of Pharmacy, Monash University,
Subang Jaya, Selangor, Malaysia, 8 Department of Microbiology, All India Institute of Medical Sciences,
Gorakhpur, India, 9 Department of Community Medicine and School of Public Health, Postgraduate Institute
of Medical Education and Research, Chandigarh, India, 10 Tribhuvan University Teaching Hospital, Institute
of Medicine, Kathmandu, Nepal, 11 Department of Microbiology, Dr. D. Y. Patil Medical College, Hospital and
Research Centre, Dr. D. Y. Patil Vidyapeeth, Pune, Maharashtra, India, 12 Harvard Medical School, Boston,
MA, United States of America
*
OPEN ACCESS
Citation: Jamil H, Idrees M, Idrees K, Tariq W,
Sayyeda Q, Asghar MS, et al. (2023) Sociodemographic determinants of Monkeypox virus
preventive behavior: A cross-sectional study in
Pakistan. PLoS ONE 18(8): e0279952. https://doi.
org/10.1371/journal.pone.0279952
Editor: Jan Rychtář, Virginia Commonwealth
University, UNITED STATES
Received: December 18, 2022
Accepted: March 29, 2023
Abstract
Background
Monkeypox (mpox), re-emerging zoonotic infectious disease, is striking the world with serious public health concerns, especially in non-endemic countries. The public’s knowledge
and attitude towards the monkeypox virus (MPXV) influence their adherence to preventive
strategies. Therefore, we aimed to assess the public’s knowledge, attitudes, and perceptions (KAP) of MPXV in Pakistan.
Published: August 10, 2023
Peer Review History: PLOS recognizes the
benefits of transparency in the peer review
process; therefore, we enable the publication of
all of the content of peer review and author
responses alongside final, published articles. The
editorial history of this article is available here:
https://doi.org/10.1371/journal.pone.0279952
Copyright: © 2023 Jamil et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which
permits unrestricted use, distribution, and
reproduction in any medium, provided the original
author and source are credited.
Data Availability Statement: All relevant data are
within the manuscript and its Supporting
Information files.
Methods
We collected data for this cross-sectional study from 1040 participants via online selfreported questionnaire from July 5th, 2022, to August 1st, 2022. The questionnaire consisted
of a total of 29 items in four sections, assessing socio-demographics, knowledge, attitudes,
and practices regarding MPXV. The data were analyzed using IBM SPSS V.25, and factors
associated with MPXV knowledge, attitude, and practices were identified by using logistic
regression analyses.
Results
A total of 1040 participants were included. 61.4% were male, and 57.2% had graduation
level education. Only 34.4% had good knowledge about MPXV, and 30% knew the effectiveness of the smallpox vaccine against MPXV. 41.7% had a positive attitude, 48.6%
agreed that it is a fatal disease, and 44.6% were in favour of banning travel from endemic to
PLOS ONE | https://doi.org/10.1371/journal.pone.0279952 August 10, 2023
1 / 16
PLOS ONE
Funding: The author(s) received no specific
funding for this work.
Competing interests: The authors have declared
that no competing interests exist.
Monkeypox (mpox) virus knowledge among the Pakistani population
non-endemic regions. 57.7% had good practices, and 69.9% would use protective measures if MPXV became an epidemic. Binary logistic regression analysis revealed that gender and education significantly impacted knowledge (p<0.05). While monthly income status
had a significant impact on attitudes (p<0.05). The practices were positively correlated with
gender and education (p<0.05).
Conclusion
The majority of study participants had inadequate levels of knowledge, and attitudes regarding MPXV. To prevent the emergence and spread of MPXV in Pakistan, a comprehensive
strategic framework for public health education must be established and implemented.
Introduction
The monkeypox virus (MPXV), a member of the POXVIRIDAE family of the genus Orthopoxvirus, is the pathogen responsible for monkeypox (mpox) fever, a zoonotic infectious disease
[1]. The first known outbreak of the virus in monkeys was discovered in 1958 at an animal
research centre in Copenhagen, Denmark, giving rise to the term "monkeypox" [2]. MPXV
was not recognized as a human virus until 1970 when the virus was isolated from a child in the
Democratic Republic of the Congo (DRC) who had symptoms of suspected smallpox infection
[3]. The potential modes of MPXV transmission are either animal-human or human-human.
Animal-human transmission is associated with direct contact with the blood, body fluids, and
cutaneous or mucosal wounds of infected animal hosts [4]. Close contact with respiratory
secretions, infected patient objects or surroundings, an infected person’s skin lesions, and sexual contact with an infected person who has genital and groin lesions can cause human-tohuman transmission [5]. However, in the recent multi-country MPXV outbreak, the majority
of MPXV cases have primarily been reported among men who have had sex with men (MSM)
[6–8].
Human mpox has clinical features that are strikingly similar to those of smallpox, but less
severe [9, 10]. After an incubation period of 10 to 14 days, the majority of patients experience
prodromic symptoms, including fever, malaise, and enlarged lymph nodes. About 90% of
patients infected with MPXV develop lymphadenopathy [11, 12]. After an initial prodromal
period, a centrifugally distributed maculopapular rash developed. Lesions develop from macules to papules, vesicles, pustules, and eventually crust over in two to four weeks [13]. Treatment of MPXV is mainly symptomatic. The smallpox vaccination is 85% effective in
protecting against mpox [14]. However, Modified Vaccinia Ankara-Bavarian Nordic
(MVA-BN), an authorized vaccine, and the antiviral medications tecovirimat and brincidofovir are not easily available [15, 16].
In 2003, the United States reported the first MPXV outbreak in humans outside of Africa,
with 70 cases, which was associated with the importation of exotic pets from Ghana [17]. Since
then, the incidence in endemic (...truncated)